Skip to content
Axe Capital logo Axe Capital Trading News

McDonald's Has Lost a Fifth of Its Value in 2026. Is It Time to Buy?

2026-10-23 10:27 •Keith Noonan •The Motley Fool Negative Axe Cap view: Neutral •Rates•Equities•Earnings•Capital Returns•Consumer•Retail •MCD

Axe Cap view

McDonald’s Downturn: Hold Off for Now

McDonald’s has lost a fifth of its value due to weak traffic and new challenges, raising questions about its near-term prospects.

McDonald’s is under pressure globally from shifting consumer habits and the rising popularity of GLP-1 diet drugs, which suppress appetite and hurt demand for fast food. The stock’s fall of around 20% this year reflects these serious business challenges. Its price-to-earnings ratio near 19 and a 3% dividend yield look tempting on paper, but earnings growth is sluggish at about 5% annually. For South African investors, the link is indirect but clear: trending health-conscious behavior globally has echoes here and could hurt companies linked to consumer staples or food retail. While big names like Shoprite and Woolworths could be less exposed, the risk of weak consumer spending remains, especially if the rand weakens against the dollar, pushing up import costs and inflation. this is just our opinion and not financial advice

How I would invest

Wait on McDonald’s for now; better entry points may appear once earnings recover or growth prospects improve. Meanwhile, keep an eye on Shoprite for resilience in local retail as food inflation stays elevated.

What I would watch
  • MCD
  • Shoprite
  • USD/ZAR
What could go wrong
  • GLP-1 drugs suppressing fast food demand longer than expected
  • Rand weakening which pressures local consumer inflations and margins
How strongly I feel

6/10

McDonald's stock has declined nearly 20% in 2026 and 28% from its lifetime high, facing headwinds including declining consumer traffic, challenging unit economics, and potential demand impacts from GLP-1 diet drugs. While the stock's forward P/E ratio of ~19 and 3% dividend yield appear attractive, the company's slow earnings growth (5% YoY) and persistent business challenges suggest patient investors may find better entry points.

Our take is based on reporting first published by The Motley Fool.

Read the original story